Senate bill offers provisions for Precision Medicine Initiative

A bill introduced in the Senate would "provide for the implementation of" the Precision Medicine Initiative.

Sen. Lamar Alexander (R-Tenn.) introduced the bill, "Advancing Precision Medicine Act of 2016," which would advance the initiative through the development of networks of scientists to carry out the initiative's mission, develop new approaches for addressing related issues and any other activities the Department of Health and Human Services (HHS) deems appropriate to make headways in the initiative.

The bill suggests HHS coordinates with the Secretary of Energy and the private sector to discuss the "advanced supercomputing needs" required by the initiative.

While legislators approved $200 million for the initiative this year, this bill contains no language on funding.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.